Recruitment of CD8+ T Cells into Bone Marrow Might Explain the Suppression of Megakaryocyte Apoptosi

来源 :中华医学会血液学分会第九次全国造血干细胞移植学术会议 | 被引量 : 0次 | 上传用户：hbchens

【摘要】

：

Background PT =PLT≤80 × 109/L,w/recovery of other cell count w/o apparent cause of thrombocytopenia Kim DH,et al.J Korean Med Sci,2006,21(1);46-51Kim DH et al.Bone Marrow Transplant,2006,37(1): 101-10

【作者】

：

Feng Fei-er

【机构】

：

Peking University People's Hospital Institute of Hematology, Peking University

【出处】

：

中华医学会血液学分会第九次全国造血干细胞移植学术会议

【发表日期】

：

2015年4期

下载到本地 , 更方便阅读

下载此文赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

其他文献

The role of intestinal microbiota during allogeneic bone marrow transplantation

" The important role of intestinal flora in various outcomes after allogeneic BMT has been recognized for many decades in both mouse and man.Recent technologies such as 16S RNA-sequencing and whole ge

会议

Novel Pretransplant Conditioning Therapy for advanced Leukemia

Although the long-term disease control rate after myeloablative chemotherapy with allogeneic hemopoietic stem cell transplantation (allo-HSCT) is high, the benefit is typically offset by high treatmen

会议

Mesenchymal stem cells (MSC) are known to accumulate at the sites of inflammation as well as damaged tissues.MSCalso possess an immunomodulatory activity, and therefore MSCcan be utilized for the trea

会议

Strategy of Decitabine in different stage of Allo-HSCT for AML/MDS

High-Risk AML/MDS----Great challenge of Transplantation allo-HSCT is a potentially curative therapy for patients with high-risk AML/MDS.Significant advances in therapeutic approaches, including the us

会议

Future of HSCT in Aging Country-Japanese Perspective

Proportion of elderly population (age 65 ≤)is rapidly growing in Japan Characteristics of aged HSCs Low repopulation potential Less homing Myeloid lineage bias Higher risk of malignant transformation

会议

Post-transplantcyclophosphamide for GvHD prophylaxis in matched sibling donor allogeneic hematopoiet

Currently, standard GvHD prophylaxis in matched sibling donor allogeneic hematopoietic stem cell transplant is the combination of short course methotrexate and calcineurin inhibitor including cyclospo

会议

The identification and pathological roles of IL-22 in acute graft-versus-host disease following allo

Immunopathogenesis of GVHD Central role of CD4+ T cells in GVHD Recent studies on Th22/IL-22 in GVHD Administration of IL-22 enhanced thymus recovery in mouse after total body irradiation.(Science 201

会议

Hematopoietic Stem Cell Transplantation and Bone Marrow Microenvironment

Leukemia remains a serious disease with high morbidity and mortality Elizabeth W,et al.CA Cancer J Clin.2014 Cornelissen JJ,et al.Blood,2007allo-HSCT is an effective treatment for leukemia Allo-HSCT t

会议

Uniform Conditioning Regimen and Identical GVHD Prophylaxis for Haploidentical, Unmanipulated, G-CSF

Background During the last years, hematopoietic stem cell transplant from haploidentical donor is increasing by using the unmanipulated graft.We report an update of the results of allogeneic bone marr

会议

Hematopoietic Stem Cell Transplantation in treatment of Philadelphia Chromosome-Positive Acute Lymph

Background Ph+ ALL is a high-risk subset of ALL that has an extremely poor prognosis Since the introduction of TKI to combination chemotherapy regimens, the majority of newly diagnosed Ph+ ALL patient

会议

Recruitment of CD8+ T Cells into Bone Marrow Might Explain the Suppression of Megakaryocyte Apoptosi

其他学术论文